All sponsors

Ever Supreme Bio Technology Co., Ltd.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-18
ACTIVE TRIALS5
PHASE 3 / 2-30
RECRUITING4
READOUTS ≤12 MONTHS2
READOUT SLIPPED >6 MO60%

Delay Index: of 5 active trials registered more than a year ago, 3 have moved their primary completion (readout) date by more than 6 months since first registration (median +22.0 months). See all sponsors →

Open Ever Supreme Bio Technology Co., Ltd. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
Allogeneic umbilical cord mesenchymal stem cells
NCT06147986
P2RecruitingST Elevation Myocardial Infarction412027-06-24
CAR001
NCT06150885
P1/2RecruitingSolid Tumor602027-06-30
autologous dendritic cells
NCT04115761
P2RecruitingGBM242027-12-30 (+72 mo)
UMSC01
NCT05501418
P1/2Active, not recruitingCOVID-19 Infection752027-12-31 (+48 mo)
UMSC01
NCT05532943
P1/2RecruitingMultiple Sclerosis412028-10-31 (+22 mo)